Azanza garckeana is an important food plant and herbal medicine in tropical Africa. This study was aimed at reviewing the nutritional value, the phytochemical compounds, ethnomedicinal uses and validated pharmacological properties of A. garckeana. The extensive literature survey revealed that ripe fruit carpels of A. garckeana are edible and widely used as food additives throughout the distributional range of the species. Azanza garckeana is also traditionally used to treat or manage at least 22 human diseases and ailments. The species is used as herbal medicine for diseases and ailments such as chest pains, cough, infertility, liver problems, menstruation problems and sexually transmitted infections. Multiple classes of compounds including alkaloids, amino acids, ascorbic acid, carotenoids, cyanogenic glucosides, flavonoids, lipids, phenols, saponins and tannins have been isolated from A. garckeana. Pharmacological studies on A. garckeana indicate that the species has a wide range of pharmacological activities such as antibacterial, antifungal, antihyperglycemic, antimalarial, antioxidant and iron absorption. Azanza garckeana is worth to be subjected to detailed scientific investigations for elucidating its chemical, nutritional and toxicological properties. Such detailed research should also include experimental animal studies, randomized clinical trials and target-organ toxicity studies involving A. garckeana and its derivatives.
How to cite this article:
Alfred Maroyi , 2017. Azanza garckeana Fruit Tree: Phytochemistry, Pharmacology, Nutritional and Primary Healthcare Applications as Herbal Medicine: A Review. Research Journal of Medicinal Plants, 11: 115-123.
In tropical Africa, Azanza garckeana (F. Hoffm.) Exell and Hillc. is among the popular multipurpose fruit trees, characterized by edible fruits with different plant parts used as herbal medicines and plant products sold to local markets generating substantial incomes for the household1. The World Agroforestry Centre identified A. garckeana as one of the fruit trees that should be integrated in the domestication process in farming systems to support nutritional, health and income security of local communities in tropical Africa2. For centuries, local communities in developing countries and marginalized areas have relied on wild edible fruits as food, medicines and nutritional supplements. In recent decades, there has been a resurgence of interest in wild edible fruits as they are known to broaden the food, nutritional security and livelihood needs of the poor and those people living in marginalized areas3,4. Accumulated evidence generated over the years categorize large proportion of wild edible fruits as both food and medicines as the plants are characterized by several micronutrients and allelochemicals that are important for human nutrition and health5,6. These nutritional and medicinal properties of wild edible fruits enable some people to use wild edible fruits as medicines and also broaden the diversity of the human diet, nutritional options, vitamins and minerals. Medicinal properties of wild edible fruits include their antioxidant effects which play a crucial role in the prevention of chronic ailments such as heart disease, cancer, diabetes, hypertension, stroke and alzheimers disease by combating oxidative stress5. Research by Glew et al.1 and Lamien-Meda et al.6 revealed that wild edible fruits are characterized by remarkable nutrient values as well as being an excellent source of minerals, fibre, vitamins C, A and E, polyphenols, ascorbic acid and fatty acids that add flavour and colour to the diet. Some researchers like Leonti7 argued that the consumption of fruits, spices and vegetables are perceived as healthy and endowed with prophylactic effects against modern lifestyle diseases.
This study reviewes on A. garckeana throughout its distributional range in tropical Africa. Therefore, this study was aimed at reviewing the nutritional value, the phytochemical compounds, ethnomedicinal uses and validated pharmacological properties of A. garckeana. This review focusing on A. garckeana is important as the species is deemed essential and opens the possibility for utilizing both its nutritional and nutraceutical properties. Azanza garckeana has great potential as high-value nutraceutical and an important source of several bioactive compounds which can be used as dietary supplements of functional foods.
Plant profile: Azanza garckeana is a member of the Malvaceae family. The generic name "Azanza" is derived from the word "Azania", a word meaning black and surviving in Zanzibar8. The specific name "garckeana" is in honour of Professor August Garcke (1819-1904), a German botanist and plant collector who specialized in pharmacognosy8,9. Synonyms of A. garckeana include Bupariti garckeana (F. Hoffm.) Rothm., Shantzia garckeana (F.Hoffm.) Lewton and Thespesia garckeana F. Hoffm.8 Azanza garckeana has been recorded in Botswana, Burundi, Democratic Republic of Congo (DRC), Kenya, Malawi, Mozambique, Namibia, Nigeria, South Africa, South Sudan, Sudan, Tanzania, Zambia and Zimbabwe. The species occurs in a wide range of warmer parts of Southern, Eastern and Western Africa in open woodlands, wooded grasslands, thickets, riverine vegetation and rocky places. It grows naturally over a range of altitudes from 0-2000 m above sea level, from semi-arid areas receiving lowest annual rainfall of 250 mm and highest rainfall of 1270 mm10.
Azanza garckeana is a shrub or small tree, growing up to 10 m tall, with stem diameter at breast height of upto 25 cm9,10. The leaves are alternate, simple, round, 3-5 lobe upto 20×20 cm in size, subcircular in outline and palmately with 3-5 lobes9. The leaf lobes are rounded to broadly tapering at the apex, the base is cordate, margins are entire, 5-7 veined from the base, sparsely hairy above, woolly and leathery below with a petiole upto 13 cm long9. The flowers are 6 cm in diameter, yellow or purplish in colour with dark purple or dark red centre9. The peduncle is 2-7 cm long, the calyx is fused, with 9-10 teeth, each tooth up to 12 mm long and petals are 6×4 cm in size9. The staminal tube is 10-12 mm long with 2-5 cm long filaments9. The fruit is a round woody capsule about 35 mm in diameter, red when mature, covered with short dense hairs, clearly divided into 4 or 5 segments9. The seeds are 10×7 mm in size, hemispheric, with a brownish woolly floss9.
Dietary and medicinal uses of Azanza garckeana: The ripe fruit carpels of A. garckeana are edible and widely consumed throughout the distributional range of the species (Table 1). Azanza garckeana is also used a food additive (Table 1) with the jelly or syrup from the species added into soups or made into porridge and occasionally dried to be reconstituted later11. Considerable quantities of A. garckeana fruits are sold in local markets in Botswana, Kenya, Zambia and Zimbabwe2,12,13. The species is semi domesticated in Botswana, Nigeria, Zambia and Zimbabwe where local people grow the species in home gardens and crop fields2,13-16.
|Table 1:||Food value and ethnomedicinal uses of Azanza garckeana in tropical Africa|
Azanza garckeana has been identified as one of the few plant species that should be integrated in the domestication process in farming systems in sub-Saharan Africa to support nutritional, medicinal and income security of local communities2,17,18. According to Van Wyk18, the fruits of A. garckeana have potential in the development of new food and beverage products.
The bark, fruits, leaves, roots and stems of A. garckeana are reported to possess diverse medicinal properties and used to treat or manage various diseases and ailments throughout its distributional range (Table 1). Total of 22 traditional medicinal uses of A. garckeana are documented in literature (Table 1) from 9 countries in tropical Africa, representing 64.3% of the countries where the species is indigenous. The country with the highest ethnomedicinal uses is Nigeria (nine) based on 4 literature records, followed by Zimbabwe with 7 uses and 2 literature records, Democratic Republic of Congo (DRC) with 4 uses based on 2 literature records and Malawi with three uses based on a single literature record (Table 1). Root infusion of A. garckeana is taken orally as remedy for chest pains, cough and menstruation in Nigeria, Zimbabwe and Kenya19-21. The root and stem bark decoction of A. garckeana is taken orally as remedy for gonorrhoea, sexually transmitted diseases and syphilis in Malawi, Nigeria and Zambia22-25. The leaf, stem, root decoction or ripe fruits of A. garckeana are taken orally as remedy for infertility and liver problems in Botswana, Kenya, Malawi, Nigeria16,20,22,24,26,27. In Nigeria, fruit poultices are applied on abscesses16,21 and ripe fruits are taken orally as aphrodisiac27. In Sudan, ripe fruits are taken orally for anemia28, while in Tanzania, the root decoction is taken by pregnant women to induce labour29. In Zimbabwe, the root decoction of A. garckeana is taken orally as antiemetic, as remedy for madness or mental illness, retained placenta and root infusion is dropped into ear as remedy for earache19,30,31. In the DRC, the leaf or root decoction of A. garckeana is taken orally as remedy for diabetes, edema, epilepsy and membrane rupture32,33. In Malawi, the root decoction of A. garckeana is taken orally for fever while in Zambia, people suffering from malaria are advised to eat raw fruit of the species or cook the fruit and eat it as relish23,34. The root decoction of A. garckeana is mixed with roots of Sterospermum kunthianum Cham. and taken orally as remedy for asthma in Malawi22.
Phytochemical composition of Azanza garckeana: Multiple classes of compounds including alkaloids, amino acids, ascorbic acid, carotenoids, cyanogenic glucosides, flavonoids, lipids, phenols, saponins and tannins (Table 2, 3) have been isolated from A. garckeana fruits, leaves, roots, seeds and stem bark25,39,40.
|Table 2:||Chemical composition of fruits, leaves, roots, seeds and stem bark of Azanza garckeana|
|*Range represents standard deviation|
Some of the documented phytochemicals are recommended by nutritionists because of their health benefits as they are considered to be responsible for positive health outcomes. Zhang et al.41 argued that phytochemicals such as alkaloids, flavones, saponins, steroids, tannins and triterpenoids isolated from fruits, vegetables and grains exert a protective effect against the development chronic diseases such as cardiovascular diseases (CVD), diabetes and cancers. According to Zhang et al.41 the protective role of phytochemicals may be associated with their antioxidant activity, since over production of oxidants (reactive oxygen species and reactive nitrogen species) in the human body is involved in the pathogenesis of many chronic diseases. Nkafamiya et al.25 isolated amino acids from fruits and leaves of A. garckeana with aspartic acid, glutamic acid, leucine and lysine being the most abundant amino acids constituting 9.67-12.97 g/100 g (Table 3).
Detection, isolation and purification of chemical compounds from fruit pulp, heartwood, roots and stem bark of A. garckeana has been done through mass spectrometry (MS) and nuclear magnetic resonance (NMR) for structural elucidation of the compounds (Table 4). Letcher and Shirley42 isolated the following compounds from heartwood of A. garckeana, O-naphthoquinones 6, mansonones E 7, mansonones F 8, mansonones G 9, mansonones H 10, azanzone A 11 and azanzone B 12 (Table 4). Mutindi43 isolated the following phenolic compound disesquiterpene aldehydes from the crude root extract of A. garckeana, gossypol 1, 6, 6-Dimethoxygossypol 2, 6-Methoxygossypol 3, stigmasterol 4, E-docosyl 3-(3,4-dihydroxyphenyl) acrylate 5 and betulinic acid 13. Masila et al.44 isolated gossypol 1, 6, 6-Dimethoxygossypol 2, 6-Methoxygossypol 3 from the root extract of A. garckeana and the stem bark yielded stigmasterol 4, E-Docosyl- 3-(3,4-dihydroxyphenyl) acrylate 5 and betulinic acid 13.
Pharmacological activities: A number of pharmacological activities of A. garckeana have been reported in literature justifying some of its ethnomedicinal uses. These include antibacterial27,43,44, antifungal27,43,44, antihyperglycemic32, antimalarial45, antioxidant21 and iron absorption28 activities.
Antibacterial: Mutindi43 evaluated antibacterial activities of crude root extract of A. garckeana and pure compounds isolated from the roots of the species which included gossypol 1, 6, 6-Dimethoxygossypol 2, 6-Methoxygossypol 3, stigmasterol4, E-docosyl 3-(3,4-Dihydroxyphenyl) acrylate 5 and betulinic acid 13 against Eschericia coli, Enterococcus faecalis, Enterococcus faecium and Staphylococcus aureus using ciprofloxacin as control. Compounds gossypol 1, 6, 6-Dimethoxygossypol 2 and 6-Methoxygossypol 3 exhibited antibacterial activities against Enterococcus faecalis and Enterococcus faecium with half maximal inhibitory concentration (IC50), minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) values ranging from 0.89-20 μg mL1 43. Gossypol 1 exhibited antibacterial activity against Staphylococcus aureus with IC50 value of 6.98 μg mL1 43. Similarly, Masila et al.44 evaluated antibacterial activities of compounds gossypol 1, 6, 6-Dimethoxygossypol 2 and 6-Methoxygossypol 3 isolated from A. garckeana against Enterococcus faecium and Staphylococcus aureus using ciprofloxin, methicillin and vancomycin as controls. Compound gossypol 1 showed strong activity against Enterococcus faecium with IC50/MIC/MBC values of 1.71/4.82/19.31 μM44.
|Table 3:||Amino acids isolated from fruits and leaves of Azanza garckeana|
|Table 4:||Chemical compounds isolated and characterized from Azanza garckeana|
Compounds 6, 6-Ttramethoxygossy pol 2 and 6-Methoxygossypol 3 were less active with IC50/MIC/MBC values of 2.73/4.70/9.40 μM and 6.14/18.32/18.32 μM against Enterococcus faecium. Compound gossypol 1 demonstrated modest activities against Staphylococcus aureus with IC50 value of 9.15 μM44. In another study, Dikko et al.27 evaluated antibacterial activities of fruit pulp ethyl acetate, n-hexane and methanol extracts of A. garckeana against Enterococci, Escherichia coli, Helicobacter pylori, Proteus mirabilis, Pseudomonas aeruginosa and Staphylococcus aureus using agar diffusion method. Ethyl acetate fraction of A. garckeana was the most active with MIC value of 0.625 mg mL1 against Escherichia coli, while MIC and MBC values of fractions against the rest of bacteria species ranged between 1.25-2.5 mg mL1 27. These findings somehow confirm the species antibacterial potential and its usefulness in the treatment and management of abscesses16,21 and syphilis24 in Nigeria, gonorrhoea in Malawi22 and Nigeria25 and sexually transmitted diseases in Zambia23.
Antifungal: Mutindi43 evaluated antifungal activities of crude root extract of A. garckeana and pure compounds isolated from the roots of the species which included gossypol 1, 6, 6-Dimethoxygossypol 2, 6-Methoxygossypol 3, stigmasterol 4, E-docosyl 3-(3,4-Dihydroxyphenyl) acrylate 5 and betulinic acid 13 against Candida albicans, Candida glabrata, Candida krusei and Aspergillus fumigatus using ampotericin B as control. Azanza garckeana crude root extract showed strong antifungal activity of 100 % inhibition against Candida glabrata at a concentration of 50 μg mL1. Compound 6-Methoxygossypol 3 exhibited strong antifungal activity against Candida glabrata with IC50 value of <0.8 μg mL1 while gossypol 1 exhibited activity against Candida glabrata with IC50 value of 3.2 μg mL1 43. Similarly, Masila et al.44 evaluated antifungal activities of compounds gossypol 1, 6, 6-Dimethoxygossypol 2 and 6-Methoxygossypol 3 isolated from A. garckeana against Candida glabrata using amphotericin B as control. Compound gossypol 1 demonstrated modest activities against Candida glabrata with IC50 values of 0.73 μM44. In another study, Dikko et al.27 evaluated antifungal activities of fruit pulp ethyl acetate, n-hexane and methanol extracts of A. garckeana against Candida albicans, Candida krusei and Candida tropicalis using agar diffusion method. Best antifungal activities were demonstrated by ethyl acetate, n-hexane and methanol fractions of A. garckeana with MIC value of 1.25 mg mL1 against Candida krusei27. Ethyl acetate extract demonstrated the best minimum fungicidal concentration (MFC) of 2.5 mg mL1 against Candida albicans and Candida tropicalis27.
Antihyperglycemic: Amuri et al.32 evaluated the hypoglycemic and antihyperglycemic activities of aqueous leaf extracts of A. garckeana by administering 500 mg kg1 to guinea pigs (Cavia porcellus), both in glucose baseline conditions and in oral glucose tolerance test with follow-up over 210 min. In oral glucose tolerance test, A. garckeana was active with inhibition of glycemia increase of 36.9% compared with the hyperglycemic inhibition rate of glibenclamide (50%)32. This data support the traditional use of A. garckeana leaf decoction as herbal medicine for diabetes in DRC32.
Antimalarial: Connelly et al.45 evaluated antimalarial activities of aqueous and organic fractions of A. garckeana against Plasmodium falciparum. Azanza garckeana showed weak antimalarial activity with median inhibitory concentration which was >3 μg mL1 43. Antimalarial evaluations carried out by Connelly et al.45 demonstrated weak activities but such findings may imply that A. garckeana has bioactive constituents with potential in controlling mosquito vectors.
Antioxidant: Mshelia et al.21 evaluated antioxidant potential of petroleum ether, ethyl acetate, acetone, methanol and water stem bark extracts of A. garckeana using the DPPH (2,2-Diphenyl-1-picrylhydrazyl) radical scavenging activity. The methanol stem bark extracts exhibited antioxidant activity with IC50 value of less than 100 μg mL1 while acetone extracts exhibited activity with IC50 value of 160 μg mL1 against the standard ascorbic acid activity with IC50 value of 220 μg mL121. These antioxidants activities of stem bark are probably due to the presence of flavonoids and phenolics46. There is now a global trend towards the use of natural phenolics as antioxidants and functional ingredients due to their perceived safety and prevalence in wild edible fruits47.
Iron absorption: Ahmed et al.28 evaluated iron absorption capability of aqueous extract of A. garckeana fruits in vivo by using everted gut sacs of wistar albino rats. Ahmed et al.28 administered 2 g kg1 b.wt. of A. garckeana aqueous extract to iron deficient rats for 3 weeks in a nutritional anemia experimental model. Administration of A. garckeana extracts caused slight alterations on hematological parameters of the nutritionally iron deficient rats except on red blood cells counts of these animals28. Thus, A. garckeana extract was found to have stimulating iron absorption properties when used on in vitro iron absorption model. This effect may justify its use for treatment of iron deficiency anemia in Sudan28 as this plant contributes to enhancement of iron deficiency rather than providing the body with rich iron source. Thus this effect of A. garckeana extract may be attributed to its saponins contents causing an increase in production of red blood cells and hence increasing their numbers28.
Cytotoxicity: Mshelia et al.21 evaluated cytotoxicity activities of petroleum ether, ethyl acetate, acetone, methanol and water stem bark extracts of A. garckeana using the brine shrimp lethality test. The concentration killing 50% (LC50) of the shrimps was 3.98 μg mL1 for acetone extract, methanol extract exhibited LC50 of 47.66 μg mL1, ethyl acetate extracts (LC50 of 100 μg mL1), water extracts (LC50 of 138.04 μg mL1) and petroleum ether extract exhibited LC50 value of greater than 1000 μg mL1. Recently, Omosa et al.48 evaluated the cytotoxicity of dichloromethane and methanol (1:1) extract of A. garckeana stem bark using the resazurin reduction assay against CCRF-CEM leukemia cell line. The dichloromethane and methanol extract of A. garckeana stem bark displayed cytotoxicity towards leukemia CCRF-CEM cells with IC50 value of 85.0 μg mL1 48. Compound gossypol 1 isolated from Thespesia populnea exhibited cytotoxic and elastase inhibitory activities49,50. These results obtained from cytotoxic evaluations indicate the possibility that some plant parts of A. garckeana may be toxic or contain some cytotoxic compounds. Previous research by Randel et al.51 revealed that gossypol 1 is toxic to non-ruminant animals and this has limited the use of cotton seed meal as a dietary source of protein for mono-gastric animals.
CONCLUSION AND RECOMMENDATION
It was concluded that such detailed research will be important as an indication of the potential nutraceutical and economical utility of A. garckeana as an important source of bioactive phytochemicals, edible fruits and food additive. Some of the pharmacological properties of A. garckeana documented so far, may be attributed to various compounds including alkaloids, flavonoids and phenolics. The contemporary research done so far involving A. garckeana is promising as some of the nutritional, phytochemical and pharmacological evidence may be used to explain and support the documented ethnomedicinal uses, nutritional and nutraceutical values.
Further research on the phytochemistry, pharmacological properties, pharmacokinetics and clinical studies of A. garckeana will enhance the ethnopharmacology, nutritional and nutraceutical value of the species and also create awareness on the species importance in improving human health in tropical Africa. There should be experimental animal studies, randomized clinical trials and target-organ toxicity studies involving A. garckeana and its derivatives. It will be important to investigate the isolation of the bioactive compounds, mechanisms of action and safety of such bioactive compounds. Such information may be useful for further studies on A. garckeana fruit for its applications in pharmaceutical industries. Further research on the antinutritive, enzymatic and molecular effects on human health will be needed to motivate further interest in the use of A. garckeana fruits.
Azanza garckeana demonstrated several ethnomedicinal uses, nutritional and nutraceutical values throughout its distributional range in tropical Africa. The overall results suggest that A. garckeana parts contain nutrients, minerals phytochemical compounds that are useful for human health. Azanza garckeana fruits are a good source of flavonoids and tannins, indicating considerable potential of A. garckeana fruit as a resource for dietary health supplement.
The author would like to express his gratitude to the National Research Foundation (NRF grant number T398) and Govan Mbeki Research and Development Centre (GMRDC, grant number C169), University of Fort Hare for financial support to conduct this research.
Ahmed, R.H., M.S. El Hassan and H.M. El Hadi, 2016. Potential capability of Azanza garckeana fruits aqueous extract on enhancement of iron absorption in Wistar albino rats. Int. J. Adv. Res. Biol. Sci., 3: 245-250.
Akinnifesi, F.K., F.R. Kwesiga, J. Mhango, A. Mkonda, T. Chilanga and R. Swai, 2004. Domesticating priority for miombo indigenous fruit trees as a promising livelihood option for small-holder farmers in Southern Africa. Acta. Hort, 632: 15-30.
Amuri, B., M. Maseho, L. Simbi, P. Okusa, P. Duez and K. Byanga, 2017. Hypoglycemic and antihyperglycemic activities of nine medicinal herbs used as antidiabetic in the region of lubumbashi (DR Congo). Phytother. Res., 31: 1029-1033.
Annamalai, T., G.V. Rao and T. Mukhopadhyay, 2013. Isolation of an elastase inhibitor, (+)-gossypol from the bark of Thespesia populnea plant. Der Pharm. Lett., 5: 312-315.
Augustino, S., J.B. Hall, F.B. Makonda and R.C. Ishengoma, 2011. Medicinal resources of the miombo woodlands of Urumwa, Tanzania: Plants and its uses. J. Med. Plants Res., 5: 6352-6372.
Boonsri, S., C. Karalai, C. Ponglimanont, S. Chantrapromma and A. Kanjana-Opas, 2008. Cytotoxic and antibacterial sesquiterpenes from Thespesia populnea. J. Nat. Prod., 71: 1173-1177.
Bunderson, W.T., Z.D. Jere, L.M. Hayes and H.S.K. Phombeya, 2002. Common Agroforestry Species in Malawi. Malawi Agroforestry Extension Project, Lilongwe, Malawi, Pages: 74.
Chikamai, B., M. Tchatat, J. Tieguhong and O. Ndoye, 2009. Forest management for non-wood forest products and services in sub-Saharan Africa. Discov. Innov., 21: 50-59.
Chinsembu, K.C., 2016. Ethnobotanical study of plants used in the management of HIV/AIDS-related diseases in Livingstone, Southern Province, Zambia. Evid.-Based Complement. Alter. Med., Vol. 2016. 10.1155/2016/4238625
Connelly, M.P.E., E. Fabiano, I.H. Patel, S.M. Kinyanjui, E.K. Mberu and W.M. Watkins, 1996. Antimalarial activity in crude extracts of Malawian medicinal plants. Ann. Trop. Med. Parasitol., 90: 597-602.
Dikko, Y.J., M.E. Khan, T.A. Tor-Anyiin, J.V. Anyam and U.A. Linus, 2016. In vitro antimicrobial activity of fruit pulp extracts of Azanza garckeana (F. Hoffm.) Exell and Hillc. and isolation of one of its active principles, Betulinic acid. Br. J. Pharm. Res., 14: 1-10.
Esther, K.I., K.Z. Kleph, K.K. Mariette, Y.N. Sylvie and W.O.T. Andre et al., 2017. Plants used by pregnant women at Kipushi city in democratic republic of Congo: Prevalence and indications. Open Access Library J., Vol. 4. 10.4236/oalib.1103390
Gelfand, M., S. Mavi, R.B. Drummond and B. Ndemera, 1985. The Traditional Medical Practitioner in Zimbabwe: His Principles of Practice and Pharmacopoeia. Mambo Press, Zimbabwe, ISBN-13: 9780869223505, Pages: 411.
Glew, R.S., D.J. Vanderjagt, L.T. Chuang, Y.S. Huang, M. Millson and R.H. Glew, 2005. Nutrient content of four edible wild plants from west Africa. Plant Foods Hum. Nutr., 60: 187-193.
Hedberg, I. and F. Staugard, 1989. Traditional Medicinal Plants in Botswana: Traditional Medicinal Plants. Ipelegeng Publishers, Gaborone, Botswana.
Hines, D.A. and K. Eckman, 1993. Indigenous Multipurpose Trees of Tanzania: Uses and Economic Benefits for People. Cultural Survival Canada: Development Services Foundation of Tanzania, Tanzania, ISBN: 9780969707509, Pages: 261.
Kanene, K.M., 2016. Indigenous practices of environmental sustainability in the Tonga community of southern Zambia. Jamba: J. Disaster Risk Stud., Vol. 8. 10.4102/jamba.v8i1.331
Lako, J., V.C. Trenerry, M. Wahlqvist, N. Wattanapenpaiboon, S. Sotheeswaran and R. Premier, 2007. Phytochemical flavonols, carotenoids and the antioxidant properties of a wide selection of Fijian fruit, vegetables and other readily available foods. Food Chem., 101: 1727-1741.
Lamien-Meda, A., C.E. Lamien, M.M.Y. Compaore, R.N.T. Meda and M. Kiendrebeogo et al., 2008. Polyphenol content and antioxidant activity of fourteen wild edible fruits from Burkina Faso. Molecules, 13: 581-594.
Leonti, M., 2012. The co-evolutionary perspective of the food-medicine continuum and wild gathered and cultivated vegetables. Genet. Resour. Crop Evol., 59: 1295-1302.
Letcher, R.M. and I.M. Shirley, 1992. O-Naphthoquinones from the heartwood of Azanza garckeana. Phytochemistry, 31: 4171-4172.
Maroyi, A. and A. Cheikhyoussef, 2017. Traditional knowledge of wild edible fruits in southern Africa: A comparative use patterns in Namibia and Zimbabwe. Indian J. Tradit. Knowledge, 16: 385-392.
Maroyi, A., 2011. The gathering and consumption of wild edible plants in Nhema communal area, Midlands Province, Zimbabwe. Ecol. Food Nutr., 50: 506-525.
Maroyi, A., 2011. An ethnobotanical survey of medicinal plants used by the people in Nhema communal area, Zimbabwe. J. Ethnopharmacol., 136: 347-354.
Maroyi, A., 2012. Local plant use and traditional conservation practices in Nhema communal area, Zimbabwe. Int. J. Afr. Renaissance Stud.-Multi-Inter- and Transdisciplin., 7: 109-128.
Maroyi, A., 2013. Traditional use of medicinal plants in South-central Zimbabwe: Review and perspectives. J. Ethnobiol. Ethnomed., Vol. 9. 10.1186/1746-4269-9-31
Masila, V.M., J.O. Midiwo, J. Zhang, B.M. Gisacho and R. Munayi et al., 2015. Anti-vancomycin-resistant Enterococcus faecium and E. faecalis activities of (-)-gossypol and derivatives from Thespesia garckeana. Nat. Prod. Commun., 10: 613-616.
Maundu, P.M., G.W. Ngugi and C.H.S. Kabuye, 1999. Traditional Food Plants of Kenya. National Museums of Kenya, Nairobi, Kenya, Pages: 270.
Mbabu, P. and L. Wekesa, 2004. Status of Indigenous Fruits in Kenya. In: Review and Appraisal on the Status of Indigenous Fruits in Eastern Africa. A Report Prepared for IPGRI-SAFORGEN in the Framework of AFREA/FORNESSA, Chikamai, B., O. Eyog-Matig and M. Mbogga (Eds.). Kenya Forestry Research Institute, Nairobi, Kenya, pp: 35-58.
Michael, K.G., L.U. Onyia and S.B. Jidauna, 2015. Evaluation of phytochemicals in Azanza garckeana (Goron tula) seed. IOSR J. Agric. Vet. Sci., 8: 71-74.
Mojeremane, W. and S.O. Tshwenyane, 2004. Azanza garckeana: A valuable edible indigenous fruit tree of Botswana. Pak. J. Nutr., 3: 264-267.
Morris, B., 1996. Chewa Medical Botany: A Study of Herbalism in Southern Malawi. International African Institute, London.
Mshelia, E.H., E.M. Watirahyel, A.U. Maigari, C. Yohanna and F. Ismail, 2016. Cytotoxicity and antioxidant activity of stem bark extracts of Azanza garckeana (kola of Tula). Eur. J. Pure Applied Chem., 3: 16-24.
Mutindi, M.V., 2014. Phytochemical investigation of Harrisonia abyssinica and Thespesia garckeana for antiplasmodial and antimicrobial compounds. M.Sc. Thesis, University of Nairobi, Nairobi.
Ndhlala, A.R., C.H. Mupure, K. Chitindingu, M.A.N. Benhura and M. Muchuweti, 2006. Antioxidant potentials and degrees of polymerization of six wild fruits. Scient. Res. Essay, 1: 87-92.
Ndubani, P. and B. Hojer, 1999. Traditional healers and the treatment of sexually transmitted illnesses in rural Zambia. J. Ethnopharmacol., 67: 15-25.
Nkafamiya, I.I., B.P. Ardo, S.A. Osemeahon and A. Akinterinwa, 2015. Evaluation of nutritional, non-nutritional, elemental content and amino acid profile of Azanza garckeana (Goron Tula). Br. J. Applied Sci. Technol., 12: 1-10.
Ochokwu, I.J., A. Dasuki and J.O. Oshoke, 2015. Azanza garckeana (goron tula) as an edible indigenous fruit in north eastern part of Nigeria. J. Biol. Agric. Healthcare, 5: 26-31.
Omosa, L.K., J.O. Midiwo, V.M. Masila, B.M. Gisacho and R. Munayi et al., 2016. Cytotoxicity of 91 Kenyan indigenous medicinal plants towards human CCRF-CEM leukemia cells. J. Ethnopharmacol., 179: 177-196.
Orwa, C., A. Mutua, R. Kindt, R. Jamnadass and A. Simons, 2009. Azanza garckeana (F. Hoffm.) Exell et Hillc.). Agroforestry Database Tree Reference and Selection Guide Version 4.0. http://www.worldagroforestry.org/treedb/AFTPDFS/Azanza_garckeana.PDF.
Palmer, E. and N. Pitman, 1972. Trees for Southern Africa Covering All Known Indigenous species in republic of South Africa, South West Africa, Botswana, Lesotho and Swaziland, Vol. 3, A.A. Balkema, Cape Town, South Africa.
Randel, R.D., C.C. Chase and S.J. Wyse, 1992. Effects of gossypol and cottonseed products on reproduction of mammals. J. Anim. Sci., 70: 1628-1638.
Saka, J.D.K. and J.D. Msonthi, 1994. Nutritional value of edible fruits of indigenous wild trees in Malawi. For. Ecol. Manage., 64: 245-248.
Schmidt, E., M. Lotter and W. McCleland, 2002. Trees and Shrubs of Mpumalanga and Kruger National Park. Jacana Media, Johannesburg, South Africa, ISBN-13: 9781919777306, Pages: 702.
Soladoye, M.O. and O.O. Oyesiku, 2008. Taxonomy of Nigerian Medicinal Plants. In: A Textbook of Medicinal Plants from Nigeria, Odugbemi, T. (Ed.). University of Lagos Press, Lagos, Nigeria, ISBN: 978-978-48712-9-7, pp: 93-150.
Storrs, A.E.G., 1979. Know Your Trees: Some of the Most Common Trees Found in Zambia. The Forest Department, Ndola, Pages: 380.
Suliman, A.M.E., I.Y. Difa and Z.A. Salih, 2012. The nutritive value of jakjak (Azanza garckeana L.) fruit and its utilization in juice production. Asian J. Biol. Sci., 5: 209-215.
Taylor, F. and B. Kwerepe, 1995. Towards Domestication of Some Indigenous Fruit Trees in Botswana. In: Improvement of Indigenous Trees of Miombo Woodlands of Southern Africa, Maghembe, J.A., Y. Ntupanyama and P.W. Chirwa (Eds.). ICRAF, Nairobi, Kenya, pp: 113-134.
Van Wyk, B.E., 2011. The potential of South African plants in the development of new medicinal products. S. Afr. J. Bot., 77: 812-829.
Wu, S.B., C. Long and E.J. Kennelly, 2013. Phytochemistry and health benefits of jaboticaba, an emerging fruit crop from Brazil. Food Res. Int., 54: 148-159.
Zhang, Y.J., R.Y. Gan, S. Li, Y. Zhou, A.N. Li, D.P. Xu and H.B. Li, 2015. Antioxidant phytochemicals for the prevention and treatment of chronic diseases. Molecules, 20: 21138-21156.